Which hedge funds own RNAC? CARTESIAN THERAPEUTICS INC, Q2 2026 13F holders
HealthcareBiotechnologyFollow
18 tracked hedge funds disclosed a position in RNAC (CARTESIAN THERAPEUTICS INC) in their Q2 2026 13F filings, worth $48.2m in total. The largest holder by portfolio weight is 683 Capital Management, LLC at 0.6% of its book. 10 opened a new position this quarter: CM Management, LLC, Diadema Partners LP, Persistent Asset Partners Ltd, ADAR1 Capital Management, LLC. 2 exited: Diametric Capital, LP, Citadel Advisors LLC.
18
Holders
Tracked managers whose filing for the quarter reports a long equity position in the security.
10
New this quarter
Holders whose previous filing (at most two quarters earlier) did not report the security.
2
Exited this quarter
Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
$5.0m
Inflow, new holders
Combined value of the positions the new holders reported for the quarter.
$911k
Outflow, exits
Combined value the exiting managers reported for the security in their previous filing.
$48.2m
Combined value
Sum of the holders' reported positions in the security.
1.5%
Share of managers holding
Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.